ריספרדל 3 מג İsrail - İbranice - Ministry of Health

ריספרדל 3 מג

j-c health care ltd - risperidone - טבליות מצופות פילם - risperidone 3 mg - risperidone - risperidone - risperdal is indicated for the management of schizophrenia and manifestation of psychotic disorders. the antipsychotic efficacy of risperdal was established in short-term (6 to 8-weeks) controlled trials of schizophrenic inpatients. risperdal is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.risperdal is indicated for the short-term treatment (up to 6 weeks) of persistent aggression in patients with moderate to severe alzheimer’s dementia unresponsive to non-pharmacological approaches and when there is a risk of harm to self or others. conduct and other disruptive disorders: treatment of behavioral disorders expressed by impulse control disorders or self-alienated-aggressive or treatment-requiring behavioral disorders with reduced or substandard intelligence. treatment should not be given to children under the age of 5 years.risperdal is indicated for the treatment of mania in bipolar disorder. these episodes are char

אינווגה 3 מג İsrail - İbranice - Ministry of Health

אינווגה 3 מג

j-c health care ltd - paliperidone - טבליות עם שחרור נרחב - paliperidone 3 mg - paliperidone - paliperidone - invega is indicated for : - treatment of schizophrenia . - acute treatment of schizoaffective disorder as monotherapy. - acute treatment of schizoaffective disorder as an adjunct to mood stabilizers and/or antidepressants.

אינווגה 6 מג İsrail - İbranice - Ministry of Health

אינווגה 6 מג

j-c health care ltd - paliperidone - טבליות עם שחרור נרחב - paliperidone 6 mg - paliperidone - paliperidone - invega is indicated for : - treatment of schizophrenia . - acute treatment of schizoaffective disorder as monotherapy. - acute treatment of schizoaffective disorder as an adjunct to mood stabilizers and/or antidepressants.

אינווגה 9 מג İsrail - İbranice - Ministry of Health

אינווגה 9 מג

j-c health care ltd - paliperidone - טבליות עם שחרור נרחב - paliperidone 9 mg - paliperidone - paliperidone - invega is indicated for : - treatment of schizophrenia . - acute treatment of schizoaffective disorder as monotherapy. - acute treatment of schizoaffective disorder as an adjunct to mood stabilizers and/or antidepressants.

קספליון 50 מג İsrail - İbranice - Ministry of Health

קספליון 50 מג

j-c health care ltd - paliperidone as palmitate - תרחיף להזרקה - שחרור נרחב - paliperidone as palmitate 100 mg / 1 ml - paliperidone - paliperidone - xeplion is indicated for the acute and maintenance treatment of schizophrenia in adults.

רמיניל 4 מ"ג İsrail - İbranice - Ministry of Health

רמיניל 4 מ"ג

j-c health care ltd - galantamine as hydrobromide 4 mg - film coated tablets - galantamine - reminyl is indicated for the symptomatic treatment of mild to moderately severe dementia of the alzheimer type.

רמיניל 8 מ"ג İsrail - İbranice - Ministry of Health

רמיניל 8 מ"ג

j-c health care ltd - galantamine as hydrobromide 8 mg - film coated tablets - galantamine - reminyl is indicated for the symptomatic treatment of mild to moderately severe dementia of the alzheimer type.

רמיניל 8 מג PRC İsrail - İbranice - Ministry of Health

רמיניל 8 מג prc

j-c health care ltd - galantamine as hydrobromide - קפסולות בשחרור ממושך - galantamine as hydrobromide 8 mg - galantamine - galantamine - reminyl is indicated for the smptomatic treatment of mild to moderately severe dementia of the alzheimer type.

רמיניל 24 מג PRC İsrail - İbranice - Ministry of Health

רמיניל 24 מג prc

j-c health care ltd - galantamine as hydrobromide - קפסולות בשחרור ממושך - galantamine as hydrobromide 24 mg - galantamine - galantamine - reminyl is indicated for the smptomatic treatment of mild to moderately severe dementia of the alzheimer type.

מיגרלב İsrail - İbranice - Ministry of Health

מיגרלב

manon pharm ltd. - buclizine hydrochloride; codeine phosphate; paracetamol - טבליה - paracetamol 500 mg; codeine phosphate 8 mg; buclizine hydrochloride 6.25 mg - buclizine, combinations - buclizine, combinations - treatment of migraine attacks, including accompanying symptoms: headache, nausea and vomiting.